Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen’s Sharer: Mostly, ‘I Was An Awful Listener’
Pharmalot
Monday, April 16, 2012 - 1:41pm
tags:
Amgen, Kevin Sharer, Pharma CEOs
FDA Schedules Meeting With Cellceutix on New Psoriasis Drug
Yahoo/Marketwire
Monday, April 16, 2012 - 11:58am
tags:
FDA, Cellceutix, psoriasis, Prurisol
Insider Buy At Novavax Spurs Speculation
Seeking Alpha
Monday, April 16, 2012 - 11:57am
tags:
Novavax
Halozyme Falls After FDA Demands More Data
Bloomberg
Monday, April 16, 2012 - 11:52am
tags:
FDA, Halozyme, HyQ, Baxter International
Achillion: A Compelling 'Buy' Candidate Now
Motley Fool
Monday, April 16, 2012 - 11:51am
tags:
Achillion, ACH-1625, ACH-2684, ACH-2928
How Will Dendreon be Affected by the STOCK Act?
Motley Fool
Monday, April 16, 2012 - 11:30am
tags:
STOCK Act, Dendreon, insider trading, GSK, Pfizer, Novartis, Sanofi
Johnson & Johnson Won't Blow Out Earnings But Still Worth $72.50
Forbes
Monday, April 16, 2012 - 11:28am
tags:
JNJ, earnings
Endocyte Doubles on Ovarian Drug Partnership With Merck
Bloomberg
Monday, April 16, 2012 - 11:28am
tags:
Merck, Endocyte, vintafolide, ovarian cancer
Provectus Pharma treatment viewed positively by doctors
The Fly on the Wall
Monday, April 16, 2012 - 11:27am
tags:
Provectus, physicians, PV-10, metastatic melanoma
Vanda buys Lilly's experimental drug
Reuters
Monday, April 16, 2012 - 11:25am
tags:
Vanda, Eli Lilly, VLY-686, alcoholism
Piramal buys Bayer molecular imaging portfolio
Yahoo/AP
Monday, April 16, 2012 - 11:24am
tags:
Bayer, molecular imaging, Piramal Healthcare
How Does Johnson & Johnson Boost Its Returns?
Motley Fool
Sunday, April 15, 2012 - 12:31pm
tags:
JNJ
Pfizer Will Plummet On New Quigley Lawsuit Developments
Seeking Alpha
Sunday, April 15, 2012 - 12:30pm
tags:
Pfizer, lawsuits
Pfizer: Quality Dividend Stock At A Bargain Price
Seeking Alpha
Sunday, April 15, 2012 - 12:29pm
tags:
Pfizer
Samsung eyes generic biological medicines
Financial Times, UK
Sunday, April 15, 2012 - 12:27pm
tags:
Samsung, generics, biogenerics
Spectrum Will Surge Higher On FOTOLYN Approval
Seeking Alpha
Sunday, April 15, 2012 - 12:25pm
tags:
Spectrum Pharmaceuticals, Fotolyn, lymphoma, T-cell lymphoma
Curis Operable BCC Human Data: Early Results And Further Commentary
Seeking Alpha
Sunday, April 15, 2012 - 12:23pm
tags:
Erivedge, Curis, Roche, basal cell carcinoma
Actos Lawsuits Gaining Momentum In Illinois State Court
DrugWatch
Saturday, April 14, 2012 - 1:41pm
tags:
Actos, diabetes, lawsuits
3 Outperforming Small Caps Bought Up By Insiders And Hedge Funds
Seeking Alpha
Saturday, April 14, 2012 - 1:38pm
tags:
Furiex Pharmaceuticals, Pacira
Valeant in Expansion Mode - Analyst Blog
Nasdaq
Saturday, April 14, 2012 - 1:36pm
tags:
Valeant Pharmaceuticals, Pedinol Pharmacal, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.